Proton Bio

company

About

Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.

  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
¥520M
Industries
Biopharma,Biotechnology,Medical
Founded date
Jan 1, 2018
Number Of Employee
251 - 500
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥520M
Proton Bio has raised a total of ¥520M in funding over 2 rounds. Their latest funding was raised on Aug 19, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 2022 Series B ¥520M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Proton Bio is funded by 2 investors. China Merchants Securities and Huatai Health Fund are the most recent investors.
Investor Name Lead Investor Funding Round
China Merchants Securities Series B
Huatai Health Fund Series B